New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 24, 2022, Prasco launched an authorized brand alternative of GSK’s Flovent HFA (fluticasone propionate) inhalation aerosol.
Download PDF
Return to publications
